Announcement from Drive Medical
PORT WASHINGTON, N.Y., Oct. 1, 2012—Drive Medical commenced the manufacturing and distribution of the Evo/Global Medical respiratory and SmartDose product lines effective October 1, 2012. Evo/Global Medical has been a leading manufacturer of respiratory products, including suction canisters, nebulizers, 50 PSI compressors and aerosol products, along with its technologically advanced patented SmartDose line of oxygen conserving devices. The transition of the manufacturing and distribution of these products will be seamless to all customers.
Harvey Diamond, chairman and CEO of Drive Medical, says, “We are pleased to broaden our capabilities and product line in the respiratory product category. By manufacturing these products, we continue our aggressive respiratory growth strategy, which we began last year with the acquisition of Inovo/CHAD Therapeutics. We are committed to this category by offering the best products and services to our customers.”
The SmartDose oxygen conserving devices and certain Evo/Global Medical respiratory products will continue to be manufactured in the U.S. through Inovo/CHAD Therapeutics, a division of Drive, in its ISO certified facilities located in Naples, Fla. “With the addition of the SmartDose line of oxygen conserving devices, Drive/CHAD will now own all of the advanced technologies for auto-adjusting oxygen conserving devices; specifically those oxygen conservers which match dose to patient activity level by using respiratory rate or movement,” according to Rich Kocinski, president of Inovo/CHAD Therapeutics.
According to Mitchell Yoel, Drive’s EVP of business development and government affairs, “Manufacturing and distributing the Evo/Global Medical line of respiratory products builds on the momentum that Drive’s respiratory category has generated, and provides Drive’s customers, the Evo/Global Medical customers and the DME industry at large with access to innovative and quality driven products with a stable supply chain and value-added educational programs and services.”
Inovo/CHAD Therapeutics is a leading manufacturer of oxygen conserving devices, regulators, and other respiratory products into the home care, long-term care, hospital and emergency markets. Inovo/CHAD Therapeutics manufactures a broad line of oxygen conserving devices and regulators under private-label for several leading manufacturers and distributors as well as under the CHAD Therapeutics brand.